Status:
TERMINATED
USZ BioResource COVID-19
Lead Sponsor:
Regina Grossmann
Conditions:
COVID19
Eligibility:
All Genders
18+ years
Brief Summary
Mono-centric. Blood sampling for biobank development, including linkage to patient data (resource for research on COVID19).
Eligibility Criteria
Inclusion
- m/f age \> 18 years
- SARS-CoV-2 infektion (according to WHO guideline)
- hospitalisation, general ward
- acceptable language knowledge
- voluntary IFC and biobank appendix
Exclusion
- contra indication for blood sampling
Key Trial Info
Start Date :
April 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04414657
Start Date
April 9 2020
End Date
September 30 2021
Last Update
November 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich, Clinical Trials Center
Zurich, Switzerland, 8091